NINGBO INNO PHARMCHEM CO.,LTD. plays a pivotal role in the pharmaceutical industry by supplying essential chemical intermediates. Among these, Methyl 4-(Bromomethyl)-3-Methoxybenzoate, identified by CAS number 70264-94-7, holds significant strategic importance. This compound is a cornerstone in the synthesis of Zafirlukast, a crucial medication for managing chronic asthma, thereby impacting both patient health and the fine chemical market. This article explores the precise chemical attributes and strategic value of this compound.

The physical form of Methyl 4-(Bromomethyl)-3-Methoxybenzoate, a white to off-white crystalline powder, immediately signifies its high purity, a prerequisite for any pharmaceutical intermediate. Its molecular formula, C10H11BrO3, and molecular weight of 259.096, are fundamental data points that ensure accuracy and predictability in complex organic synthesis. An assay of ≥98.0% reinforces its suitability for demanding applications such as Zafirlukast intermediate synthesis, where consistency and quality are paramount for producing effective treatments.

The principal application of Methyl 4-(Bromomethyl)-3-Methoxybenzoate is its integral role in the manufacturing process of Zafirlukast. Zafirlukast is a highly selective oral leukotriene receptor antagonist that has significantly improved the management of chronic asthma. By inhibiting the action of leukotrienes, which are key mediators of inflammation and airway constriction in asthma, Zafirlukast offers substantial relief to patients. The reactive bromomethyl group within Methyl 4-(Bromomethyl)-3-Methoxybenzoate is essential for driving the chemical reactions required to build the intricate Zafirlukast molecule, positioning it as a vital asthma medication intermediate.

The global pharmaceutical supply chain relies on dependable sources for high-quality materials. NINGBO INNO PHARMCHEM CO.,LTD. contributes significantly by ensuring the consistent availability of high purity methyl 4-(bromomethyl)-3-methoxybenzoate. Manufacturers depend on this level of quality and reliability for their critical Zafirlukast intermediate synthesis, which directly influences the efficacy and safety of the final drug product. The importance of this pharmaceutical intermediate chemical cannot be overstated.

Beyond its primary use, Methyl 4-(Bromomethyl)-3-Methoxybenzoate is also a valuable compound in the broader organic synthesis and fine chemical sectors. Its specific chemical structure and reactivity make it a versatile tool for researchers developing new synthesis methodologies or exploring novel pharmaceutical agents. The availability of quality fine chemical CAS 70264-94-7 supports continuous innovation across scientific disciplines. The strategic positioning of such intermediates ensures the robustness of the pharmaceutical manufacturing ecosystem.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to empowering the pharmaceutical industry with superior chemical intermediates. Our expertise in synthesis and commitment to quality assurance make us an ideal partner for companies seeking reliable sourcing. For any inquiries regarding Zafirlukast intermediate synthesis, custom chemical production, or our extensive range of pharmaceutical intermediates, please contact us. We are ready to provide tailored solutions and competitive quotations to meet your project requirements.